Accès ouvert

Paxlovid and Molnupiravir Approved to Manage COVID-19: A Countdown for SARS CoV-2 Variant Apocalypse.

Article scientifique 2021 Anglais

Résumé

I wish to recommend not to approve either Paxlovid or molnupiravir in those countries that are still considering their license, to revoke the emergency use authorization in those countries that issued it, and it is very unfortunate for humanity that safe, generic and highly effective Kelleni’s African protocol used to manage pediatric, adult and pregnant COVID-19 patients is not, yet, adopted by those countries where COVID-19 is wasting thousands of lives daily and I humbly suggest the reasons for this long-lasting ignorance are not medical or scientific.

Citer ce document

Kelleni, M. (2021). Paxlovid and Molnupiravir Approved to Manage COVID-19: A Countdown for SARS CoV-2 Variant Apocalypse.. https://doi.org/10.31219/osf.io/qsfkh

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0